Hikma Pharmaceutical | HIK - Рыночная капитализация





Рыночная капитализация Изменить Дата
Almirall EUR 2.41B 345.65M 2026-05
argenx SE USD 39.98B 4.4B 2026-05
AstraZeneca USD 301.25B 13.1B 2026-03
Autolus Therapeutics Ltd USD 529.63M 0 2026-05
Bayer EUR 37.69B 1.01B 2026-05
Fresenius EUR 22.59B 5B 2026-05
Genmab DKK 20.48B 1.02B 2025-12
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
GRIFOLS EUR 3.69B 1.9B 2026-05
Hikma Pharmaceutical USD 4.63B 1.42B 2025-12
Lakefront Biotherapeutics EUR 1.58B 147.61M 2026-05
Lonza CHF 39.68B 980.61M 2025-06
Merck EUR 51.28B 4.5B 2026-05
Orion EUR 9.83B 890.75M 2026-03
Recordati EUR 10.41B 151.99M 2026-05
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.27B 605.48M 2026-03
UCB EUR 46.41B 13.94B 2025-12